
Acadia Pharmaceuticals Announces Broad U.S. Availability of DAYBUE STIX for the Treatment of Rett Syndrome
Acadia Pharmaceuticals Expands U.S. Access to DAYBUE STIX for Patients with Rett Syndrome Acadia Pharmaceuticals has announced that DAYBUE® STIX (trofinetide) for oral solution—a newly developed powder formulation of its…












